Table: Delta-Fly Pharma - Q1 parent results

Delta-Fly Pharma

09/08/2024 07:07

Aug 9 (Reuters)- 
             Delta-Fly Pharma, Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended        Year to   
                Jun 30, 2024        Jun 30, 2023       Mar 31, 2025  
                   LATEST             YEAR-AGO            LATEST     
                   RESULTS             RESULTS           FORECAST    
  Operating     loss 497 mln        loss 275 mln        loss 1.82    
  Recurring     loss 499 mln        loss 280 mln        loss 1.83    
  Net           loss 500 mln        loss 280 mln        loss 1.83    
  EPS          loss 60.78 yen      loss 43.07 yen    loss 222.34 yen 
  Ann Div                                NIL               NIL       
  -Q2 div                                NIL               NIL       
  -Q4 div                                NIL               NIL       
  
  NOTE - Delta-Fly Pharma, Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4598.T